A resolution to express the sense of the Senate regarding the Medicare national coverage determination on the treatment of anemia in cancer patients.

(This measure has not been amended since it was introduced. The summary of that version is repeated here.)

Expresses the sense of the Senate that the Centers for Medicare & Medicaid Services should: (1) begin an immediate reconsideration of the final National Coverage Determination on the Use of Erythropoiesis Stimulating Agents in Cancer and Related Neoplastic Conditions (CAG-000383N); (2) consult with members of the clinical oncology community to determine appropriate revisions to it: and (3) implement such revisions as soon as feasible, and brief Congress in advance of announcing such changes.